Aduro BioTech Obtains $119,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9b7997b0-033e-4bb2-948a-687532fe308a - Date
4/15/2015 - Company Name
Aduro BioTech - Mailing Address
626 Bancroft Way Berkeley, CA 94710 USA - Company Description
Aduro BioTech (NASDAQ: ADRO) is an immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. - Website
http://www.adurobiotech.com - Transaction Type
IPO - Transaction Amount
$119,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
